Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis

CONCLUSION: The results showed that all the AEs and irAEs of all the categories were more prevalent with ICIs.PMID:34162158 | DOI:10.1016/j.intimp.2021.107796

Source: International Immunopharmacology - June 24, 2021 Category: Allergy & Immunology Authors: Maryam Balibegloo Seyed Aria Nejadghaderi Mona Sadeghalvad Alireza Soleymanitabar Sasan Salehi Nezamabadi Amene Saghazadeh Nima Rezaei Source Type: research